The stiffened matrix forms a physical barrier against the penetration of drugs, and the study has shown that decreasing the deposited HA in the ECM benefited anti-VEGF therapy in colorectal cancer patients with liver metastasis (27). Here, VEGFA is linked to colorectal cancer.